REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 103 filers reported holding REVANCE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,099,000 | -67.8% | 45,000 | -79.1% | 0.01% | -68.4% |
| Q1 2020 | $3,411,000 | -2.2% | 215,000 | 0.0% | 0.04% | +2.7% |
| Q4 2019 | $3,489,000 | +13.2% | 215,000 | -9.3% | 0.04% | -9.8% |
| Q3 2019 | $3,081,000 | +0.7% | 237,000 | 0.0% | 0.04% | +7.9% |
| Q2 2019 | $3,060,000 | -18.1% | 237,000 | 0.0% | 0.04% | -20.8% |
| Q1 2019 | $3,735,000 | -21.7% | 237,000 | 0.0% | 0.05% | -34.2% |
| Q4 2018 | $4,771,000 | +12.3% | 237,000 | +38.6% | 0.07% | +30.4% |
| Q3 2018 | $4,249,000 | -9.5% | 171,000 | 0.0% | 0.06% | -24.3% |
| Q2 2018 | $4,694,000 | -10.9% | 171,000 | 0.0% | 0.07% | -17.8% |
| Q1 2018 | $5,267,000 | -2.4% | 171,000 | +13.2% | 0.09% | -3.2% |
| Q4 2017 | $5,398,000 | +44.1% | 151,000 | +11.0% | 0.09% | +43.1% |
| Q3 2017 | $3,747,000 | +1.4% | 136,000 | -2.9% | 0.06% | -5.8% |
| Q2 2017 | $3,696,000 | +45.6% | 140,000 | +14.8% | 0.07% | +40.8% |
| Q1 2017 | $2,538,000 | +83.0% | 122,000 | +82.1% | 0.05% | +53.1% |
| Q4 2016 | $1,387,000 | – | 67,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,415,689 | $86,106,000 | 6.66% |
| Evolutionary Tree Capital Management, LLC | 176,336 | $3,439,000 | 2.39% |
| Essex Woodlands Management, Inc. | 457,085 | $8,913,000 | 2.16% |
| HealthCor Management, L.P. | 1,423,425 | $27,757,000 | 1.85% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,112,325 | $21,690,000 | 0.86% |
| Waypoint Capital Advisors, LLC | 53,989 | $1,016,000 | 0.60% |
| Antara Capital LP | 679,600 | $13,252,000 | 0.40% |
| Rhenman & Partners Asset Management AB | 198,358 | $3,868,000 | 0.38% |
| Walleye Capital LLC | 505,701 | $9,861,000 | 0.26% |
| Polar Capital Holdings Plc | 2,456,497 | $47,902,000 | 0.22% |